Find Funding Opportunities

NIH Extramural Response to Natural Disasters and Other Emergencies

In emergency situations, the NIH’s immediate concern is for the health and safety of people and animals in the programs we oversee.  Visit the NIH Extramural Response to Natural Disasters and Other Emergencies web page for biomedical research community resources, including NIH Guide Notices and other information of particular relevance to investigators and their institutions, links to web pages listing NIH’s response to certain major events (past and present); and links to similar web sites from other Federal agencies.

 COVID-19 Funding Notices | Approved Initiative Concepts | Research Opportunity Announcements

All NINDS-related notices of funding opportunities (NOFOs), request for applications (RFAs), program announcements (PAs), and other NIH Guide announcements are listed. Search the Closed Opportunities tab to find expired opportunities. Search the Notices tab to find all Notices.

Learn more about award types and program directors and managers.

NINDS has a number of open positions for researchers and clinicians to contribute to exciting neuroscience programs - APPLY NOW!

For more focused results add quotes to indicate parameters. Example format: "search term".

Displaying 81 - 90 of 1387 Notices
Request for Information on Potential Solutions for Reducing Publication Bias Against Null Studies
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-052
Tuesday, January 30, 2024
Notice Type: NOT
Request for information
Pre-Application Webinar for RFA-NR-24-004: Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NR-24-006
Tuesday, January 30, 2024
Notice Type: NOT
The National Institute of Nursing Research is holding an applicant technical assistant webinar related to the recently released Notice of Funding Opportunity (NOFO) RFA-NR-24-004: Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional). The purpose of this initiative is to support unusually innovative intervention research addressing social determinants of health (SDOH) which, if successful, would have a major impact on preventing, reducing, or eliminating health disparities and advancing health equity. Projects should clearly demonstrate, based on the strength of the logic, a compelling potential to produce a major impact on advancing NIHs commitment to addressing SDOH to accelerate progress in improving health for all. Preliminary data are not required for this initiative. This webinar will provide an overview of the NOFO. NIH staff will discuss the purpose and scope of this funding opportunity, go over the scientific review process and review criteria, and share the specific research interests of NINR and of the participating Institutes, Centers, and Offices. NIH staff will also address questions submitted in advance of the webinar.
Notice of Change to Receipt Dates for RFA-NS-24-013: Efficacy and Safety of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Both Amyloid-Beta and Vascular Pathology (U01 - Clinical Trial Required)
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-044
Thursday, January 25, 2024
Notice Type: NOT
Pushing the RD back.
NIH Blueprint for Neuroscience Research: Request for Information (RFI) on the NIH Toolbox Assessments Conference
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-AG-23-076
Monday, January 22, 2024
Notice Type: NOT
The purpose of this Request for Information (RFI) is to seek input from the scientific community onfour affiliated measurement systems/measures: theNIH Toolbox, theNIH Infant and Toddler Toolbox (NIH Baby Toolbox),Mobile Toolbox, andMyCog for discussion at the upcomingNIH Toolbox Assessments Conference. The NIH Toolbox and NIH Baby Toolbox both were developed under the egis of theNational Institutes of Health Blueprint for Neuroscience Research (Blueprint), a collaboration among 14 participating NIH Institutes, Centers, and offices to support cross-cutting funding programs to advance research on the nervous system.
Notice of Information of Intent to Publish Research Opportunity Announcements for the NeuroNEXT Clinical Trials: Stage 1 (Preliminary) and Stage 2 (Protocol) Applications (OT2)
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-045
Friday, January 19, 2024
Notice Type: NOT
Notice of information about upcoming OTA.
Notice of Change: Extension of PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-038
Thursday, January 18, 2024
Notice Type: NOT
The purpose of this notice is to inform applicants of an extension of PAR-21-234 "NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)" by one additional council round.
Notice of Change: Extension of PAR-21-328 "Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-041
Thursday, January 18, 2024
Notice Type: NOT
The purpose of this notice is to inform applicants of an extension to PAR-21-328 "Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)".
Notice of Change: Extension of PAR-21-327 "Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)"
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-040
Tuesday, January 16, 2024
Notice Type: NOT
The purpose of this notice is to inform applicants of an extension to PAR-21-327 "Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)".
Notice of Change: Extension of PAR-21-122, PAR-21-123, PAR-21-124 Innovation Grants to Nurture Initial Translational Efforts (IGNITE) NOFOs by One Additional Council Round
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-048
Tuesday, January 16, 2024
Notice Type: NOT
The purpose of this notice is to inform applicants of an extension to PAR-21-122, PAR-21-123, PAR-21-123 Innovation Grants to Nurture Initial Translational Efforts (IGNITE) NOFOs by one additional council round.
Notice of Change: Extension of PAR-21-237 "NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)" by two council rounds
Expiration Date: Monday, January 1, 2029
NOFO Number: NOT-NS-24-033
Friday, January 12, 2024
Notice Type: NOT
The purpose of this notice is to inform applicants of an extension of PAR-21-2137 "NINDS Efficacy Clinical Trials (UG3/UH3 Clinical Trial Required)" by two additional council rounds.